This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as DSTL, located in the United Kingdom. The $9,099,202.00 contract is for the "WMD, US JTSO--UK, BASE PERIOD" and has a period of performance through July 31, 2012. The contract supports DTRA's efforts to counter chemical, biological, radiological, and nuclear threats, with MOD providing research and development services such as...
This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...
This is a federal contract award to the Ministry of Defence (doing business as DSTL), a government entity in the United Kingdom, by the Defense Threat Reduction Agency (DTRA). The $824,565 cost-plus-fixed-fee contract supports chemical agent system testing. The work, which is not set aside, involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. This includes developing medical countermeasures, diagnostic tools, conducting...
This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...
This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...
This is a federal contract award to the Ministry of Defence (MOD), doing business as D S T L, located in Great Britain, United Kingdom. The contract, valued at $4,385,034.00, is a Delivery Order contract with a Cost Plus Fixed Fee pricing type, awarded by the Defense Threat Reduction Agency (DTRA) for "ANTHRAX DETECTION - BASE" efforts. The contract has no set-aside designation. Based on the vendor's past performance, the work likely involves research and development services focused...
The Defense Threat Reduction Agency awarded a $4,387,571.00 Cost Plus Fixed Fee contract to the Ministry of Defence, doing business as D S T L, a U.K. government entity located in Great Britain. The contract is for the development of chemical and biological decision support tools, with a completion date of July 21, 2022. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, and may involve activities such as research on medical...
This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria. The contract does not have a set-aside designation. DSTL is a...
This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as D S T L (Defence Science and Technology Laboratory), a United Kingdom government entity. The contract is for research and development of pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This award is not associated with a set-aside program. The original solicitation was a...
This is a Cost Plus Fixed Fee contract valued at $1,289,074.82 awarded by the Defense Advanced Research Projects Agency (DARPA) to the Ministry of Defence (MOD) of the United Kingdom, doing business as the Defense Science and Technology Laboratory (DSTL). The contract is for the "Interfering and Co-Evolving Prevention and Therapy (INTERCEPT) PROGRAM", which involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. The work...